Entereg approved for GI surgical recovery
The FDA has approved Entereg (alvimopan capsules, from Adolor and GlaxoSmithKline) to accelerate upper and lower gastrointestinal (GI) recovery following resection surgery with primary anastomosis.
Entereg is a peripherally acting mu-opioid receptor (PAM-OR) antagonist and will be available for short-term use in hospitals registered under the Entereg Access Support and Education (E.A.S.E.) program starting in June 2008.
For more information call (888) 825-5249 or visit www.entereg.com.